Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is gaining attention not only for its blood glucose-lowering effects but also for its ability to improve liver function and reduce liver fat accumulation, which is particularly beneficial for MASLD patients who often have coexisting T2DM
Ozempic reduces inflammation even WITHOUT weight loss
Neurological symptoms caused by long-term deficiency may take several weeks to months to fully improve
PlexusDx facilitates this conversation by offering genetic predisposition insights and structured treatment pathways, helping patients and providers make informed, evidence-grounded decisions rather than assumptions about more medication equaling better results
These effects could explain why researchers are exploring whether the medicines might also benefit conditions such as depression, anxiety, bipolar disorder, and substance use disorders
2 Members who discontinued medication before one year achieved a 13.1% average weight loss 1 versus 6.8% among similar patients in other real world evidence
